Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stakeholders Warn Comparative Effectiveness Research Is No Magic Bullet

This article was originally published in The Gray Sheet

Executive Summary

As Congress moves closer to approving significant funding for comparative effectiveness programs, questions remain over how to structure a sustainable system for conducting the research and how to avoid unintended consequences in sharing the data
Advertisement

Related Content

Comparative Effectiveness Researchers Look Beyond Randomized Trials
Comparative Effectiveness Researchers Look Beyond Randomized Trials
CMS Coverage Director Steve Phurrough Will Move To AHRQ Outcomes Office
CMS Coverage Director Steve Phurrough Will Move To AHRQ Outcomes Office
CBO Says Comparative Effectiveness Research Won’t Save Money Soon
Renal Stenting Coverage Reconsidered: AHRQ Comparative Analysis Effect
Amid Calls For More Data, CMS Says It Will Retain Spinal Fusion Coverage
Amid Calls For More Data, CMS Says It Will Retain Spinal Fusion Coverage

Topics

Advertisement
UsernamePublicRestriction

Register

MT027044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel